RegentAtlantic Capital’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $2.4M | Buy |
34,195
+3,674
| +12% | +$288K | 0.07% | 184 |
|
|
2022
Q2 | $2.45M | Buy |
30,521
+2,879
| +10% | +$225K | 0.08% | 183 |
|
|
2022
Q1 | $2.1M | Buy |
27,642
+155
| +0.6% | +$12.3K | 0.06% | 217 |
|
|
2021
Q4 | $2.35M | Buy |
27,487
+1,747
| +7% | +$136K | 0.07% | 202 |
|
|
2021
Q3 | $1.95M | Sell |
25,740
-225
| -0.9% | -$17.9K | 0.06% | 212 |
|
|
2021
Q2 | $2.11M | Buy |
25,965
+1,221
| +5% | +$99.8K | 0.06% | 200 |
|
|
2021
Q1 | $1.95M | Buy |
24,744
+6,763
| +38% | +$530K | 0.07% | 193 |
|
|
2020
Q4 | $1.54M | Buy |
17,981
+1,633
| +10% | +$135K | 0.06% | 199 |
|
|
2020
Q3 | $1.26M | Sell |
16,348
-1,125
| -6% | -$85.8K | 0.06% | 203 |
|
|
2020
Q2 | $1.28M | Buy |
17,473
+1,421
| +9% | +$101K | 0.07% | 195 |
|
|
2020
Q1 | $1.06M | Sell |
16,052
-646
| -4% | -$45.6K | 0.08% | 196 |
|
|
2019
Q4 | $1.15M | Sell |
16,698
-130
| -0.8% | -$8.86K | 0.07% | 220 |
|
|
2019
Q3 | $1.24M | Sell |
16,828
-179
| -1% | -$13K | 0.08% | 207 |
|
|
2019
Q2 | $1.22M | Buy |
17,007
+954
| +6% | +$67.7K | 0.08% | 209 |
|
|
2019
Q1 | $1.1M | Sell |
16,053
-333
| -2% | -$21.5K | 0.08% | 214 |
|
|
2018
Q4 | $975K | Sell |
16,386
-3,565
| -18% | -$223K | 0.08% | 214 |
|
|
2018
Q3 | $1.34M | Sell |
19,951
-136
| -0.7% | -$9.06K | 0.1% | 193 |
|
|
2018
Q2 | $1.3M | Sell |
20,087
-1,078
| -5% | -$70.5K | 0.11% | 183 |
|
|
2018
Q1 | $1.52M | Buy |
21,165
+868
| +4% | +$62.5K | 0.13% | 171 |
|
|
2017
Q4 | $1.53M | Buy |
20,297
+145
| +0.7% | +$10.6K | 0.13% | 172 |
|
|
2017
Q3 | $1.47M | Sell |
20,152
-61
| -0.3% | -$4.4K | 0.13% | 173 |
|
|
2017
Q2 | $1.5M | Buy |
20,213
+9,032
| +81% | +$671K | 0.14% | 163 |
|
|
2017
Q1 | $818K | Buy |
11,181
+688
| +7% | +$48.2K | 0.08% | 220 |
|
|
2016
Q4 | $687K | Sell |
10,493
-15
| -0.1% | -$1.03K | 0.07% | 235 |
|
|
2016
Q3 | $779K | Buy |
10,508
+28
| +0.3% | +$2.07K | 0.08% | 223 |
|
|
2016
Q2 | $767K | Sell |
10,480
-1,259
| -11% | -$89.6K | 0.07% | 220 |
|
|
2016
Q1 | $829K | Sell |
11,739
-1,218
| -9% | -$81K | 0.09% | 184 |
|
|
2015
Q4 | $863K | Buy |
12,957
+2,150
| +20% | +$143K | 0.09% | 201 |
|
|
2015
Q3 | $686K | Sell |
10,807
-472
| -4% | -$30.8K | 0.07% | 221 |
|
|
2015
Q2 | $738K | Sell |
11,279
-3,500
| -24% | -$237K | 0.07% | 215 |
|
|
2015
Q1 | $1.02M | Sell |
14,779
-170
| -1% | -$11.8K | 0.09% | 181 |
|
|
2014
Q4 | $1.03M | Sell |
14,949
-374
| -2% | -$25.3K | 0.09% | 183 |
|
|
2014
Q3 | $999K | Buy |
15,323
+40
| +0.3% | +$2.64K | 0.09% | 177 |
|
|
2014
Q2 | $1.04M | Buy |
15,283
+1,500
| +11% | +$101K | 0.1% | 178 |
|
|
2014
Q1 | $894K | Sell |
13,783
-685
| -5% | -$43.2K | 0.09% | 187 |
|
|
2013
Q4 | $943K | Sell |
14,468
-330
| -2% | -$21.1K | 0.09% | 186 |
|
|
2013
Q3 | $878K | Buy |
14,798
+330
| +2% | +$19.6K | 0.1% | 173 |
|
|
2013
Q2 | $829K | Buy |
+14,468
| New | +$859K | 0.1% | 170 |
|
Other funds holding CL
TP
RegentAtlantic Capital's CL Position: Q3 2022 in Review
RegentAtlantic Capital increased its Colgate-Palmolive (CL) stake by 12% in Q3 2022, buying an estimated $288K and bringing the position to 34,195 shares worth $2.4M. The position accounts for 0.07% of the portfolio, ranked #184.
RegentAtlantic Capital first reported a position in CL in Q2 2013 and has held it in 38 quarters since. The position peaked at $2.45M in Q2 2022. 1,614 funds tracked by Wall St. Rank hold CL as of Q3 2022.
- RegentAtlantic Capital held 34,195 shares of Colgate-Palmolive worth $2.4M as of Q3 2022.
- RegentAtlantic Capital bought 3,674 Colgate-Palmolive shares in Q3 2022, an estimated $288K.
- Colgate-Palmolive made up 0.07% of RegentAtlantic Capital's portfolio in Q3 2022, its #184 holding.
- RegentAtlantic Capital first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 38 quarters since.
- RegentAtlantic Capital's Colgate-Palmolive position peaked at $2.45M in Q2 2022.
- 1,614 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2022.
Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.